A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)
Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
This is a double-blind, randomized, placebo-controlled, multi-center study using the oral
ORMD-0801 insulin formulation in patients with NASH and confirmed type 2 DM.